Mankind Pharma, India’s leading pharmaceutical company in the antihypertensive segment, has launched the ‘Limit White India’ campaign on World Hypertension Day. This nationwide initiative aims to raise awareness about the risks associated with excessive salt and sugar consumption, which, along with sedentary lifestyles and obesity, significantly contribute to hypertension.
Research indicates that 1 in 4 Indian adults suffer from hypertension, and 101 million people, or 11.4% of the population, live with diabetes. These conditions often coexist and exacerbate each other, increasing the risk of severe health issues such as cardiovascular diseases, stroke, and kidney failure. The campaign educates the public on reducing ‘white’ intake—salt and sugar—to improve cardiovascular health through gradual lifestyle changes.
Mankind Pharma plans a three-year awareness program, partnering with healthcare professionals nationwide to manage hypertension and diabetes. Dr. Sanjay Koul, Chief Marketing Officer of Mankind Pharma, emphasized the campaign’s importance, stating that hypertension is a silent killer and excessive salt and sugar are major contributors to uncontrolled blood pressure and sugar levels. Indians consume five times the WHO-recommended amount of sugar annually. The campaign aims to empower people to make informed health choices.
The campaign will involve cardiologists, endocrinologists, diabetologists, and general practitioners through various educational initiatives. These include journal clubs, ‘Cardiac Cognizance’ newsletters, radio awareness programs, and nationwide blood pressure screening camps.